Raymond James & Associates Glaukos Corp Put Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GKOS
# of Institutions
309Shares Held
46.9MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$767 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$267 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$261 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$227 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.69B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...